Status:
COMPLETED
Inflammation and Daily Life Study
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Inflammation
Eligibility:
All Genders
45-60 years
Phase:
EARLY_PHASE1
Brief Summary
UCLA researchers looking for healthy individuals (age 45-60) to participate in a study investigating whether an anti-inflammatory medication can impact daily life experiences. Everyday for two weeks,...
Detailed Description
Participants (ntotal=50) will be men and women, ages 45-60. All interested participants will first complete a structured telephone interview in order to assess eligibility. The study will begin with ...
Eligibility Criteria
Inclusion
- healthy adults 45-60
Exclusion
- Following a structured telephone interview, participants with the following conditions will not be able to participate:
- certain active, uncontrolled medical disorders
- use of certain medications (e.g., hypnotic and psychotropic medication, steroid use, opioid use)
- psychiatric disorders (e.g., current major depression, bipolar disorder)
- Other exclusion criteria may apply.
Key Trial Info
Start Date :
February 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 21 2024
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT03771612
Start Date
February 9 2022
End Date
June 21 2024
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Department of Psychology
Los Angeles, California, United States, 90095